DAM
AGN

DLD Asset Management’s Allergan plc AGN Stock Holding History

DLD Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-378,000
Closed -$66.9M – 93
2020
Q1 		$66.9M Buy
378,000
+78,000
+26% +$14.7M 4.21% 2
2019
Q4 		$57.4M Buy
300,000
+90,000
+43% +$16.2M 3.09% 6
2019
Q3 		$35.3M Buy
210,000
+138,755
+195% +$22.6M 1.79% 15
2019
Q2 		$11.9M Buy
+71,245
New +$9.87M 0.5% 34

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

DLD Asset Management's AGN Position: Q2 2020 in Review

DLD Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 378,000 shares — an estimated $66.9M sold.

DLD Asset Management first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $66.9M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • DLD Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • DLD Asset Management sold 378,000 Allergan plc shares in Q2 2020, an estimated $66.9M.
  • DLD Asset Management first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • DLD Asset Management's Allergan plc position peaked at $66.9M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on DLD Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.